pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,561 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 2
    PAX-1
    Bile Duct Cancer (Cholangiocarcinoma) Komipharm International Co Ltd
  • Phase 2
    PBF-999
    Prader-Willi Syndrome (PWS) Palobiofarma SL
  • Phase 2
    PBFT-02
    Frontotemporal Dementia (Pick Disease)$PASG Passage BIO, Inc.
  • Phase 2
← prev
page 22 of 53
next →
131
Pain89
Neurology1
PBGENE-HBV
Hepatitis B
$DTIL PRECISION BIOSCIENCES INC
  • Phase 2
    PBGM-01
    GM1 Gangliosidosis (Beta Galactosidase 1 Deficiency) GEMMA Biotherapeutics Inc
  • Phase 2
    PBI-05204
    Metastatic Adenocarcinoma of The Pancreas Phoenix Biotechnology Inc
  • Phase 2
    PEEL-224
    Neuroblastoma Peel Therapeutics Inc
  • Phase 2
    PER-001
    Diabetic Retinopathy Perfuse Therapeutics Inc
  • Phase 2
    PF-07868489
    Pulmonary Arterial Hypertension$PFE PFIZER INC
  • Phase 2
    PF-07872412
    Streptococcal Pneumonia$PFE PFIZER INC
  • Phase 2
    PFL-002
    Non-Small Cell Lung Cancer Pierre Fabre Pharmaceuticals Inc
  • Phase 2
    PFL-241
    Non-Small Cell Lung Cancer Laboratoires Pierre Fabre SA
  • Phase 2
    PFL-721
    Non-Small Cell Lung Cancer Laboratoires Pierre Fabre SA
  • Phase 2
    PH-10
    Xantryl
    Atopic Dermatitis (Atopic Eczema)$PVCT PROVECTUS BIOPHARMACEUTICALS, INC.
  • Phase 2
    PH-15
    Cognitive Impairment$VTGN Vistagen Therapeutics, Inc.
  • Phase 2
    PHN-031
    Osteoporosis PhytoHealth Corp
  • Phase 2
    PHN-033
    Diabetic Nephropathy PhytoHealth Corp
  • Phase 2
    PKN-605
    Atrial Fibrillation$NVS NOVARTIS AG
  • Phase 2
    PL-18
    Bacterial Vaginosis Jiangsu ProteLight Pharmaceutical And Biotechnology Co Ltd
  • Phase 2
    PL-8177
    Ulcerative Colitis$PTNT PALATIN TECHNOLOGIES INC
  • Phase 2
    PM-359
    Chronic Granulomatous Disease$PRME Prime Medicine, Inc.
  • Phase 2
    PMD-026
    Human Epidermal Growth Factor Receptor 2 Negative Breast… Phoenix Molecular Designs
  • Phase 2
    PMP-1606
    pimecrolimus
    Keratoconjunctivitis Sicca (Dry Eye) Premark Pharma GmbH
  • Phase 2
    PORT-77
    Erythropoietic Protoporphyria GondolaBio LLC
  • Phase 2
    PR-001
    Parkinson's Disease Prevail Therapeutics Inc
  • Phase 2
    PR-15
    Stroke advanceCor GmbH
  • Phase 2
    PRGN-2009
    Anal Cancer$PGEN PRECIGEN, INC.
  • Phase 2
    PRL3-ZUMAB
    Solid Tumor IISG Pte Ltd
  • Phase 2
    PROPRANOLOL HYDROCHLORIDE
    PROPRANOLOL HYDROCHLORIDE
    Retinopathy Of Prematurity Recordati Rare Diseases Inc
  • Phase 2
    PRX-115
    Gouty Arthritis (Gout)$PLX Protalix BioTherapeutics, Inc.